Amgen shares top $100 as fears fade over biosimilars

You are here: Home > Banking & Finance > Current Article

By Stephen Nellis / Friday, April 5th, 2013 / Comments Off on Amgen shares top $100 as fears fade over biosimilars

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.

Senior editor

Friday, June 14th, 2019

Thursday, June 13th, 2019

Monday, June 10th, 2019

Sponsored: